Identifying an optimum treatment strategy for patients with advanced non-small cell lung cancer
2008-01-01 Grossi, F; Gridelli, C; Aita, M; De Marinis, F
Expression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I-III Non-Small Cell Lung Cancer
2015-01-01 Grossi, F; Dal Bello, Mg; Salvi, S; Puzone, R; Pfeffer, U; Fontana, V; Alama, A; Rijavec, E; Barletta, G; Genova, C; Sini, C; Ratto, Gb; Taviani, M; Truini, M; Merlo, Df
Pleural and peripheral lung lesions: comparison of US- and CT-guided biopsy
2013-01-01 Sconfienza, Lm; Mauri, G; Grossi, F; Truini, M; Serafini, G; Sardanelli, F; Murolo, C
Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non Small-Cell Lung Cancer
2010-01-01 Scagliotti, G; Novello, S; von Pawel, J; Reck, M; Pereira, Jr; Thomas, M; Miziara, Jea; Balint, B; De Marinis, F; Keller, A; Aren, O; Csollak, M; Albert, I; Barrios, Ch; Grossi, F; Krzakowski, M; Cupit, L; Cihon, F; Dimatteo, S; Hanna, N
Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples
2016-01-01 Bonfiglio, S; Vanni, I; Rossella, V; Truini, A; Lazarevic, D; Dal Bello, Mg; Alama, A; Mora, M; Rijavec, E; Genova, C; Cittaro, D; Grossi, F; Coco, S
Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial
2014-01-01 Gregorc, V; Novello, S; Lazzari, C; Barni, S; Aieta, M; Mencoboni, M; Grossi, F; De Pas, T; de Marinis, F; Bearz, A; Floriani, I; Torri, V; Bulotta, A; Cattaneo, A; Grigorieva, J; Tsypin, M; Roder, J; Doglioni, C; Levra, Mg; Petrelli, F; Foti, S; Viganò M, ; Bachi, A; Roder, H
Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial
2017-01-01 Tiseo, M; Boni, L; Ambrosio, F; Camerini, A; Baldini, E; Cinieri, S; Brighenti, M; Zanelli, F; Defraia, E; Chiari, R; Dazzi, C; Tibaldi, C; Turolla, Gm; D'Alessandro, V; Zilembo, N; Trolese, Ar; Grossi, F; Riccardi, F; Ardizzoni, A
Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers
2003-01-01 Grossi, F; Loprevite, M; Chiaramondia, M; Ceppa, P; Pera, C; Ratto, Gb; Serrano, J; Ferrara, Gb; Costa, R; Boni, L; Ardizzoni, A
Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST)
2012-01-01 Boni, C; Tiseo, M; Boni, L; Baldini, E; Recchia, F; Barone, C; Grossi, F; Germano, D; Matano, E; Marini, G; Labianca, R; Di Costanzo, F; Bagnulo, A; Pennucci, C; Caroti, C; Mencoboni, M; Zanelli, F; Prochilo, T; Cafferata, Ma; Ardizzoni, A
Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma
2006-01-01 Ceresoli, Gl; Zucali, Pa; Favaretto, Ag; Grossi, F; Bidoli, P; Del Conte, G; Ceribelli, A; Bearz, A; Morenghi, E; Cavina, R; Marangolo, M; Parra, Hjs; Santoro, A
Simple posterior elbow dislocations: Conservative management and role of ulnar-bone coverage angle
2021-01-01 Fozzato, S.; Marin, R.; Basilico, M.; Surace, M. F.
Informal caregiving burden in advanced non-small cell lung cancer: The HABIT study
2007-01-01 Gridelli, C; Ferrara, C; Guerriero, C; Palazzo, S; Grasso, G; Pavese, I; Satta, F; Bajetta, E; Cortinovis, D; Barbieri, F; Gebbia, V; Grossi, F; Novello, S; Baldini, E; Gasparini, G; Latino, W; Durante, E; Giustini, L; Negrini, C
[Acute myocarditis in a young adult two days after Pfizer vaccination]
2021-01-01 Facetti, Sara; Giraldi, Mario; Vecchi, Andrea Lorenzo; Rogiani, Silvia; Nassiacos, Daniele
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%
2020-01-01 Cortellini, A.; Tiseo, M.; Banna, G. L.; Cappuzzo, F.; Aerts, J. G. J. V.; Barbieri, F.; Giusti, R.; Bria, E.; Cortinovis, D.; Grossi, F.; Migliorino, M. R.; Galetta, D.; Passiglia, F.; Santini, D.; Berardi, R.; Morabito, A.; Genova, C.; Mazzoni, F.; Di Noia, V.; Signorelli, D.; Tuzi, A.; Gelibter, A.; Marchetti, P.; Macerelli, M.; Rastelli, F.; Chiari, R.; Rocco, D.; Gori, S.; De Tursi, M.; Mansueto, G.; Zoratto, F.; Santoni, M.; Tudini, M.; Rijavec, E.; Filetti, M.; Catino, A.; Pizzutilo, P.; Sala, L.; Citarella, F.; Marco, R.; Torniai, M.; Cantini, L.; Targato, G.; Sforza, V.; Nigro, O.; Ferrara, M. G.; D'Argento, E.; Buti, S.; Bordi, P.; Antonuzzo, L.; Scodes, S.; Landi, L.; Guaitoli, G.; Baldessari, C.; Della Gravara, L.; Dal Bello, M. G.; Belderbos, R. A.; Bironzo, P.; Carnio, S.; Ricciardi, S.; Grieco, A.; De Toma, A.; Proto, C.; Friedlaender, A.; Cantale, O.; Ricciuti, B.; Addeo, A.; Metro, G.; Ficorella, C.; Porzio, G.
Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural Mesothelioma
2016-01-01 Truini, A; Coco, S; Genova, C; Mora, M; Dal Bello, Mg; Vanni, I; Alama, A; Rijavec E, ; Barletta, G; Biello, F; Maggioni, C; Grossi, F
Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer
2012-01-01 Salvi, S; Fontana, V; Boccardo, S; Merlo, Df; Margallo, E; Laurent, S; Morabito, A; Rijavec, E; Dal Bello, Mg; Mora, M; Ratto, Gb; Grossi, F; Truini, M; Pistillo, Mp
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
2016-01-01 Schuler, M; Yang, Jc; Park, K; Kim, Jh; Bennouna, J; Chen, Ym; Chouaid, C; De Marinis, F; Feng, Jf; Grossi, F; Kim, Dw; Liu, X; Lu, S; Strausz, J; Vinnyk, Y; Wiewrodt, R; Zhou, C; Wang, B; Chand, Vk; Planchard, D; LUX-Lung, 5 Investigators
Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non-small cell lung cancer
2007-01-01 Loprevite, M; Tiseo, M; Chiaramondia, M; Capelletti, M; Bozzetti, C; Bortesi, B; Naldi, N; Nizzoli, R; Dadati, P; Kunkl, A; Zennaro, D; Lagrasta, C; Campanini, N; Spiritelli, E; Camisa, R; Grossi, F; Rindi, G; Franciosi, V; Ardizzoni, A
Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials
2008-01-01 Ceresoli, Gl; Castagneto, B; Zucali, Pa; Favaretto, A; Mencoboni, M; Grossi, F; Cortinovis, D; Del Conte, G; Ceribelli, A; Bearz, A; Salamina, S; De Vincenzo, F; Cappuzzo, F; Marangolo, M; Torri, V; Santoro, A
Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: Baseline results of a prospective, nonrandomized feasibility trial - An alpe-adria thoracic oncology multidisciplinary group study (ATOM 002)
2007-01-01 Fasola, G; Belvedere, O; Aita, M; Zanin, T; Follador, A; Cassetti, P; Meduri, S; De Pangher, V; Pignata, G; Rosolen, V; Barbone, F; Grossi, F
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Identifying an optimum treatment strategy for patients with advanced non-small cell lung cancer | 1-gen-2008 | Grossi, F; Gridelli, C; Aita, M; De Marinis, F | |
| Expression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I-III Non-Small Cell Lung Cancer | 1-gen-2015 | Grossi, F; Dal Bello, Mg; Salvi, S; Puzone, R; Pfeffer, U; Fontana, V; Alama, A; Rijavec, E; Barletta, G; Genova, C; Sini, C; Ratto, Gb; Taviani, M; Truini, M; Merlo, Df | |
| Pleural and peripheral lung lesions: comparison of US- and CT-guided biopsy | 1-gen-2013 | Sconfienza, Lm; Mauri, G; Grossi, F; Truini, M; Serafini, G; Sardanelli, F; Murolo, C | |
| Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non Small-Cell Lung Cancer | 1-gen-2010 | Scagliotti, G; Novello, S; von Pawel, J; Reck, M; Pereira, Jr; Thomas, M; Miziara, Jea; Balint, B; De Marinis, F; Keller, A; Aren, O; Csollak, M; Albert, I; Barrios, Ch; Grossi, F; Krzakowski, M; Cupit, L; Cihon, F; Dimatteo, S; Hanna, N | |
| Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples | 1-gen-2016 | Bonfiglio, S; Vanni, I; Rossella, V; Truini, A; Lazarevic, D; Dal Bello, Mg; Alama, A; Mora, M; Rijavec, E; Genova, C; Cittaro, D; Grossi, F; Coco, S | |
| Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial | 1-gen-2014 | Gregorc, V; Novello, S; Lazzari, C; Barni, S; Aieta, M; Mencoboni, M; Grossi, F; De Pas, T; de Marinis, F; Bearz, A; Floriani, I; Torri, V; Bulotta, A; Cattaneo, A; Grigorieva, J; Tsypin, M; Roder, J; Doglioni, C; Levra, Mg; Petrelli, F; Foti, S; Viganò M, ; Bachi, A; Roder, H | |
| Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial | 1-gen-2017 | Tiseo, M; Boni, L; Ambrosio, F; Camerini, A; Baldini, E; Cinieri, S; Brighenti, M; Zanelli, F; Defraia, E; Chiari, R; Dazzi, C; Tibaldi, C; Turolla, Gm; D'Alessandro, V; Zilembo, N; Trolese, Ar; Grossi, F; Riccardi, F; Ardizzoni, A | |
| Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers | 1-gen-2003 | Grossi, F; Loprevite, M; Chiaramondia, M; Ceppa, P; Pera, C; Ratto, Gb; Serrano, J; Ferrara, Gb; Costa, R; Boni, L; Ardizzoni, A | |
| Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST) | 1-gen-2012 | Boni, C; Tiseo, M; Boni, L; Baldini, E; Recchia, F; Barone, C; Grossi, F; Germano, D; Matano, E; Marini, G; Labianca, R; Di Costanzo, F; Bagnulo, A; Pennucci, C; Caroti, C; Mencoboni, M; Zanelli, F; Prochilo, T; Cafferata, Ma; Ardizzoni, A | |
| Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma | 1-gen-2006 | Ceresoli, Gl; Zucali, Pa; Favaretto, Ag; Grossi, F; Bidoli, P; Del Conte, G; Ceribelli, A; Bearz, A; Morenghi, E; Cavina, R; Marangolo, M; Parra, Hjs; Santoro, A | |
| Simple posterior elbow dislocations: Conservative management and role of ulnar-bone coverage angle | 1-gen-2021 | Fozzato, S.; Marin, R.; Basilico, M.; Surace, M. F. | |
| Informal caregiving burden in advanced non-small cell lung cancer: The HABIT study | 1-gen-2007 | Gridelli, C; Ferrara, C; Guerriero, C; Palazzo, S; Grasso, G; Pavese, I; Satta, F; Bajetta, E; Cortinovis, D; Barbieri, F; Gebbia, V; Grossi, F; Novello, S; Baldini, E; Gasparini, G; Latino, W; Durante, E; Giustini, L; Negrini, C | |
| [Acute myocarditis in a young adult two days after Pfizer vaccination] | 1-gen-2021 | Facetti, Sara; Giraldi, Mario; Vecchi, Andrea Lorenzo; Rogiani, Silvia; Nassiacos, Daniele | |
| Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% | 1-gen-2020 | Cortellini, A.; Tiseo, M.; Banna, G. L.; Cappuzzo, F.; Aerts, J. G. J. V.; Barbieri, F.; Giusti, R.; Bria, E.; Cortinovis, D.; Grossi, F.; Migliorino, M. R.; Galetta, D.; Passiglia, F.; Santini, D.; Berardi, R.; Morabito, A.; Genova, C.; Mazzoni, F.; Di Noia, V.; Signorelli, D.; Tuzi, A.; Gelibter, A.; Marchetti, P.; Macerelli, M.; Rastelli, F.; Chiari, R.; Rocco, D.; Gori, S.; De Tursi, M.; Mansueto, G.; Zoratto, F.; Santoni, M.; Tudini, M.; Rijavec, E.; Filetti, M.; Catino, A.; Pizzutilo, P.; Sala, L.; Citarella, F.; Marco, R.; Torniai, M.; Cantini, L.; Targato, G.; Sforza, V.; Nigro, O.; Ferrara, M. G.; D'Argento, E.; Buti, S.; Bordi, P.; Antonuzzo, L.; Scodes, S.; Landi, L.; Guaitoli, G.; Baldessari, C.; Della Gravara, L.; Dal Bello, M. G.; Belderbos, R. A.; Bironzo, P.; Carnio, S.; Ricciardi, S.; Grieco, A.; De Toma, A.; Proto, C.; Friedlaender, A.; Cantale, O.; Ricciuti, B.; Addeo, A.; Metro, G.; Ficorella, C.; Porzio, G. | |
| Prognostic and Therapeutic Implications of MicroRNA in Malignant Pleural Mesothelioma | 1-gen-2016 | Truini, A; Coco, S; Genova, C; Mora, M; Dal Bello, Mg; Vanni, I; Alama, A; Rijavec E, ; Barletta, G; Biello, F; Maggioni, C; Grossi, F | |
| Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer | 1-gen-2012 | Salvi, S; Fontana, V; Boccardo, S; Merlo, Df; Margallo, E; Laurent, S; Morabito, A; Rijavec, E; Dal Bello, Mg; Mora, M; Ratto, Gb; Grossi, F; Truini, M; Pistillo, Mp | |
| Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial | 1-gen-2016 | Schuler, M; Yang, Jc; Park, K; Kim, Jh; Bennouna, J; Chen, Ym; Chouaid, C; De Marinis, F; Feng, Jf; Grossi, F; Kim, Dw; Liu, X; Lu, S; Strausz, J; Vinnyk, Y; Wiewrodt, R; Zhou, C; Wang, B; Chand, Vk; Planchard, D; LUX-Lung, 5 Investigators | |
| Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non-small cell lung cancer | 1-gen-2007 | Loprevite, M; Tiseo, M; Chiaramondia, M; Capelletti, M; Bozzetti, C; Bortesi, B; Naldi, N; Nizzoli, R; Dadati, P; Kunkl, A; Zennaro, D; Lagrasta, C; Campanini, N; Spiritelli, E; Camisa, R; Grossi, F; Rindi, G; Franciosi, V; Ardizzoni, A | |
| Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials | 1-gen-2008 | Ceresoli, Gl; Castagneto, B; Zucali, Pa; Favaretto, A; Mencoboni, M; Grossi, F; Cortinovis, D; Del Conte, G; Ceribelli, A; Bearz, A; Salamina, S; De Vincenzo, F; Cappuzzo, F; Marangolo, M; Torri, V; Santoro, A | |
| Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: Baseline results of a prospective, nonrandomized feasibility trial - An alpe-adria thoracic oncology multidisciplinary group study (ATOM 002) | 1-gen-2007 | Fasola, G; Belvedere, O; Aita, M; Zanin, T; Follador, A; Cassetti, P; Meduri, S; De Pangher, V; Pignata, G; Rosolen, V; Barbone, F; Grossi, F |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- Articoli su Riviste35047
Data di pubblicazione
- In corso di stampa25
- 2020 - 202710367
- 2010 - 201911782
- 2000 - 20097850
- 1990 - 19993601
- 1980 - 19891162
- 1970 - 1979252
- 1967 - 19698
Editore
- Edizioni Luigi Pozzi Srl:via Pana...51
- Japadre Editore, L'Aquila36
- WILEY34
- Elsevier BV:PO Box 211, 1000 AE A...31
- ELSEVIER SCIENCE BV29
- Franco Angeli Riviste SRL:viale M...28
- Springer Verlag Germany:Tiergarte...28
- -Roma: [s.n.]. -Artegierre-Esseze...26
- Elsevier B.V.23
- Royal Society of Chemistry:Thomas...21
Rivista
- PHYSICAL REVIEW LETTERS216
- LA RADIOLOGIA MEDICA180
- NUCLEAR INSTRUMENTS & METHODS IN ...176
- ASTRONOMY & ASTROPHYSICS168
- MONTHLY NOTICES OF THE ROYAL ASTR...165
- PHYSICS LETTERS. SECTION B154
- PLOS ONE152
- SCIENTIFIC REPORTS150
- THROMBOSIS AND HAEMOSTASIS145
- IL PROTAGORA140
Serie
- PROCEEDINGS OF INTERNATIONAL MATH...1
Keyword
- Humans1605
- Female801
- Male679
- Middle Aged514
- COVID-19506
- Aged475
- Adult453
- Italy337
- SARS-CoV-2310
- Treatment Outcome237
Lingua
- eng18777
- ita2898
- fre60
- spa55
- ger35
- por14
- bul9
- rus8
- gre6
- chi3
Accesso al fulltext
- no fulltext24520
- reserved5242
- open5082
- restricted107
- partially open93
- mixed2
- embargoed1